AngioDynamics (ANGO) reported a quarter ended May 2026 with an earnings surprise of +36.36% and a revenue surprise of +7.61%. The upside suggests stronger-than-expected fundamentals, which can support positive near-term stock momentum as investors look for confirmation in forward results.
AngioDynamics (ANGO) reported a quarter ended May 2026 with an earnings surprise of +36.36% and a revenue surprise of +7.61%. The upside suggests stronger-than-expected fundamentals, which can support positive near-term stock momentum as investors look for confirmation in forward results.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.45
Ticker Sentiment
